7/27/20

LIVING RAPID REVIEW: Risk of transmitting COVID-19 during nebulizer treatment   

Goldstein KM, Ghadimi K, Mystakelis H, et al. | VA Evidence Synthesis Program

Aim: To review the evidence on the risk of transmitting SARS-CoV-2, SARS, MERS, and influenza with administration of drugs via nebulizer

7/20/20

Evidence Brief: COVID-19 Post-Acute Care Major Organ Damage 

 | VA Evidence Synthesis Program

7/20/20

Evidence Brief: Mental Health Outcomes of Adults Hospitalized with COVID-19 

 | VA Evidence Synthesis Program

7/10/20

STUDY REVIEW: Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: A propensity score matched retrospective cohort study by Daniel E. Freedberg et al. 

Lewis J, Mackey K | VA Evidence Synthesis Program

Aim: To critically appraise the identified study and provide additional context for study findings.

6/26/20

RAPID RESPONSE: Corticosteroid therapy for COVID-19 infection 

Helfand M | VA Evidence Synthesis Program

Aim: To review the evidence for using corticosteroids to treat acute respiratory distress syndrome in patients with COVID-19.

6/26/20

RAPID RESPONSE: COVID-19: Intensive care unit length of stay and ventilation days 

Duan-Porter W | VA Evidence Synthesis Program

Aim: To explore the length of stay in the intensive care unit (ICU) and time on invasive mechanical ventilation for adult patients with COVID-19.

6/20/20

Antithrombotic therapies in COVID-19 Disease: a Systematic Review   

Maldonado E, Tao D, Mackey K | J Gen Intern Med

Aim: To synthesize evidence on thromboembolism incidence and outcomes with antithrombotic therapies in COVID-19.

6/19/20

United States health inequalities in COVID-19 and past epidemics and pandemics  

Ayers C, Kondo K, Saha S, et al | VA Evidence Synthesis Program

5/18/20

LIVING SYSTEMATIC REVIEW: The impact of ACE inhibitors or ARBs on severe acute respiratory illness due to SARS CoV-2     

Mackey K, King VJ, Gurley S, et al. | VA Evidence Synthesis Program

Aim: To synthesize evidence on the role of ACE inhibitor and ARB use on patient outcomes in COVID-19 as well as evidence on the benefits and harms of initiating these medications to treat patients with COVID-19.

5/15/20

PREPRINT REVIEW: Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 

Lindquist I, Mackey K, Edwards S | VA Evidence Synthesis Program

Aim: To provide author feedback and critical appraisal in a similar manner as would be provided by editorial staff of a journal.